Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China · Delayed Price · Currency is CNY

4.910

+0.050 (1.03%)

Jul 31, 2026, 3:00 PM CST

SHA:600613 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,895	1,952	2,049	2,341	2,389	2,303
Revenue Growth	-3.01%	-4.71%	-12.48%	-2.00%	3.72%	26.61%
Gross Profit	830.24	863.82	951.71	1,152	1,263	1,385
Operating Income	68.81	69.64	93.43	126.37	85.79	90.69
Net Income	36.13	38.24	71.39	57	48.55	69.62
Earnings Per Share	0.06	0.07	0.13	0.11	0.09	0.13
EPS Growth	-47.89%	-46.15%	18.18%	22.22%	-30.77%	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Manufacturing	1,123
Pharmaceutical Business	829.28
Total	1,952

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	715.07	785.24	800.27	736.17	656.49	493.8
Total Debt	90.19	209.49	217.13	253.07	285.61	312.28
Net Cash (Debt)	624.88	575.75	583.14	483.11	370.88	181.52
Net Cash Growth	8.08%	-1.27%	20.71%	30.26%	104.32%	-4.07%
Net Cash Per Share	1.07	1.05	1.06	0.93	0.69	0.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	193.79	124.47	207.79	215.59	319.23	184.26
Capital Expenditures	-24.34	-33.22	-36.39	-24.51	-26.64	-85.96
Free Cash Flow	169.45	91.26	171.39	191.08	292.59	98.3
Free Cash Flow Growth	89.47%	-46.76%	-10.30%	-34.70%	197.65%	3421.80%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.80%	44.25%	46.45%	49.20%	52.90%	60.13%
Operating Margin	3.63%	3.57%	4.56%	5.40%	3.59%	3.94%
Pretax Margin	3.70%	3.63%	4.27%	3.56%	2.65%	4.32%
Profit Margin	1.91%	1.96%	3.48%	2.44%	2.03%	3.02%
FCF Margin	8.94%	4.67%	8.37%	8.16%	12.25%	4.27%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.070	0.070	0.150	0.100	0.100	0.100
Dividend Per Share Growth	-53.33%	-53.33%	50.00%	0%	0%	-
Dividend Yield	1.43%	1.17%	2.27%	1.39%	1.30%	1.70%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	79.15	80.99	49.24	68.45	86.93	47.28
P/FCF Ratio	14.85	33.94	20.51	20.42	14.43	33.48
PS Ratio	1.33	1.59	1.72	1.67	1.77	1.43